The influence of asthma on neuroinflammation and neurodevelopment: From epidemiology to basic models

Tamayo, Juan M.; Osman, Hadley C.; Schwartzer, Jared J.; Ashwood, Paul

doi:10.1016/j.bbi.2023.12.003

Cited by 3 publications

(3 citation statements)

References 200 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Numerous studies show that AS is a disease that is associated with type 2 cytokines, such as interleukin-4 (IL-4), IL-5, and IL-13, which promote AS symptoms such as airway eosinophilia, overproduction of mucus, bronchial hyperresponsiveness, and high levels of IgE (Steinke and Borish, 2001;Kuruvilla et al, 2019;Wang et al, 2023). Similarly, symptoms of AR and food and skin allergies are induced by the acute, intermittent, or chronic type 2 (T2) inflammation and secretion of pro-inflammatory cytokines and eotaxins that can cross the blood-brain barrier, resulting in neuroinflammation (Tamayo et al, 2024). Importantly, Guedes et al (2023) demonstrated the impact of elevated IL-4 levels during cerebellar maturation and provided the first line of evidence for a mechanistical link between allergic disease and ADHD in humans.…”

Section: Discussionmentioning

confidence: 99%

Omalizumab in combination with subcutaneous immunotherapy for the treatment of multiple allergies associated with attention-deficit/hyperactivity disorder: a case report and a literature review

Ding,

2024

Front. Pharmacol.

View full text Add to dashboard Cite

We describe the case of a 10-year-old boy with asthma (AS), accompanied by allergic rhinitis (AR), food allergy (FA), and combined attention-deficit/hyperactivity disorder (ADHD), who was treated at Shanghai Renji Hospital on 11 July 2020. The efficiency of the previous treatment with salmeterol/ticlosone was poor. Treatment with montelukast sodium resulted in development of neurological symptoms. Treatment with omalizumab in combination with subcutaneous immunotherapy (SCIT) was then initiated in our department based on anti-asthmatic therapy. Symptoms of asthma were completely controlled, and FA and AR symptoms improved. The treatment regimen led to a significant improvement in ADHD symptoms and the overall quality of life of the patient. The literature search was done in the PubMed database using “attention deficit/hyperactivity disorder/ADHD” and “asthma” as keywords, and we identified 47 relevant articles. In conclusion, our results show that treating asthma with omalizumab in combination with salmeterol/ticlosone and SCIT is efficient in controlling symptoms of multiple allergies and may lead to the improvement in ADHD symptoms and the overall quality of life of pediatric patients with ADHD. While current studies suggest that allergic diseases are closely related to ADHD, there is still a lack of studies or case reports of complete treatment protocols to provide clinical clues for management of the disease.

show abstract

Section: Discussionmentioning

confidence: 99%

Omalizumab in combination with subcutaneous immunotherapy for the treatment of multiple allergies associated with attention-deficit/hyperactivity disorder: a case report and a literature review

Ding,

2024

Front. Pharmacol.

View full text Add to dashboard Cite

show abstract

“…A large body of studies have assessed the acute manifestations of inflammation in maternal and fetal organs induced by LPS, vira or poly I:C administered via intravenous, -peritoneal or -uterine routes 2 , 4 , 7 . Much less work has delineated the downstream manifestations of immunogens targeted to the lungs, including maternal airway inflammation arising from environmental dust and respiratory infections 8 – 14 . The latter are common during pregnancy: 49.6% of control mothers in the National Birth Defects Prevention Study reported respiratory infections during pregnancy 15 , 16 .…”

Section: Introductionmentioning

confidence: 99%

“…immunogens targeted to the lungs, including maternal airway inflammation arising from environmental dust and respiratory infections [8][9][10][11][12][13][14] . The latter are common during pregnancy: 49.6% of control mothers in the National Birth Defects Prevention Study reported respiratory infections during pregnancy 15,16 .…”

mentioning

confidence: 99%

Pulmonary maternal immune activation does not cross the placenta but leads to fetal metabolic adaptation

Hansen,

Krautz,

Rago

et al. 2024

Nat Commun

View full text Add to dashboard Cite

The fetal development of organs and functions is vulnerable to perturbation by maternal inflammation which may increase susceptibility to disorders after birth. Because it is not well understood how the placenta and fetus respond to acute lung- inflammation, we characterize the response to maternal pulmonary lipopolysaccharide exposure across 24 h in maternal and fetal organs using multi-omics, imaging and integrative analyses. Unlike maternal organs, which mount strong inflammatory immune responses, the placenta upregulates immuno-modulatory genes, in particular the IL-6 signaling suppressor Socs3. Similarly, we observe no immune response in the fetal liver, which instead displays metabolic changes, including increases in lipids containing docosahexaenoic acid, crucial for fetal brain development. The maternal liver and plasma display similar metabolic alterations, potentially increasing bioavailability of docosahexaenoic acid for the mother and fetus. Thus, our integrated temporal analysis shows that systemic inflammation in the mother leads to a metabolic perturbation in the fetus.

show abstract

Maternal asthma symptoms during pregnancy on child behaviour and executive function: A Bayesian phenomics approach

Husain,

Cremaschi,

Suaini

et al. 2024

Brain, Behavior, and Immunity

View full text Add to dashboard Cite

The influence of asthma on neuroinflammation and neurodevelopment: From epidemiology to basic models

Cited by 3 publications

References 200 publications

Omalizumab in combination with subcutaneous immunotherapy for the treatment of multiple allergies associated with attention-deficit/hyperactivity disorder: a case report and a literature review

Omalizumab in combination with subcutaneous immunotherapy for the treatment of multiple allergies associated with attention-deficit/hyperactivity disorder: a case report and a literature review

Pulmonary maternal immune activation does not cross the placenta but leads to fetal metabolic adaptation

Maternal asthma symptoms during pregnancy on child behaviour and executive function: A Bayesian phenomics approach

Contact Info

Product

Resources

About